Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension

Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension

Conditions: Primary Aldosteronism; Resistant Hypertension; Secondary Hypertension; Hyperaldosteronism; Mineralocorticoid Excess; Hypertension
Interventions: Other: Best Practice Advisory Computerized Alert
Sponsors: Brigham and Women’s Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 6, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments